Literature DB >> 15086595

Increased expression of transforming growth factor-alpha and epidermal growth factor receptors in rat chronic reflux esophagitis.

Yasuhiro Fujiwara1, Kazuhide Higuchi, Masaki Hamaguchi, Takashi Takashima, Toshio Watanabe, Kazunari Tominaga, Nobuhide Oshitani, Takayuki Matsumoto, Tetsuo Arakawa.   

Abstract

BACKGROUND AND AIM: Transforming growth factor-alpha (TGF-alpha), which binds to epidermal growth factor receptors (EGF-R), stimulates esophageal epithelial cell proliferation, enabling rapid repair after mucosal injury. The aim of the present study was to examine epithelial proliferation and dynamics of TGF-alpha and EGF-R gene and protein expression in rat chronic acid reflux esophagitis.
METHODS: Gastric acid reflux esophagitis was induced in Wistar rats by ligating the transitional region between the forestomach and the glandular portion, and by covering the duodenum near the pyloric ring with a small piece of an 18Fr Nélaton catheter. Epithelial cell proliferation was assessed by bromodeoxyuridine (BrdU) uptake. Expression of TGF-alpha and EGF-R mRNA and protein was assessed by reverse transcription-polymerase chain reaction (RT-PCR) and immunohistochemistry.
RESULTS: Esophageal lesions were observed in the lower and middle esophagus. Histologically, a significant increase in mucosal thickening with elongation of lamina propria papillae and basal cell hyperplasia was observed. The BrdU labeling index was significantly increased from 2.7 +/- 1.0 in normal mucosa and 2.8 +/- 1.2 in background mucosa adjacent to the esophageal lesion, to 60.3 +/- 32.7 in the lesions of chronic esophagitis. Expression of TGF-alpha and EGF-R mRNA in the esophageal lesion significantly increased compared to those in the control and background tissue, whereas treatment with rabeprazole significantly inhibited increases in TGF-alpha and EGF-R mRNA expression. According to immunohistochemical study, TGF-alpha and EGF-R revealed strong expression in esophageal lesions compared with control and background mucosa. The superficial layer of the esophagus was strongly positive for TGF-alpha and most cells in regions of basal hyperplasia had a positive reaction for EGF-R in the esophagitis lesion.
CONCLUSION: Epithelial proliferation and expression of TGF-alpha and EGF-R were significantly increased in rat chronic reflux esophagitis. Activation of TGF-alpha and EGF-R genes in response to acid reflux may facilitate rapid mucosal healing by stimulating epithelial proliferation. These results suggest that TGF-alpha and EGF-R play crucial roles in rat chronic reflux esophagitis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15086595     DOI: 10.1111/j.1440-1746.2003.03332.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  12 in total

1.  Acid challenge to the human esophageal mucosa: effects on epithelial architecture in health and disease.

Authors:  Mogens Bove; Michael Vieth; Frank Dombrowski; Lars Ny; Magnus Ruth; Lars Lundell
Journal:  Dig Dis Sci       Date:  2005-08       Impact factor: 3.199

Review 2.  ERBBs in the gastrointestinal tract: recent progress and new perspectives.

Authors:  William H Fiske; David Threadgill; Robert J Coffey
Journal:  Exp Cell Res       Date:  2008-11-07       Impact factor: 3.905

3.  Increase of epidermal growth factor receptor expression in progression of GERD, Barrett, and adenocarcinoma of esophagus.

Authors:  Guilherme Pretto; Richard Ricachenevsky Gurski; Marcelo Binato; Daniel Navarini; Wolfgan William Schmidt Aguiar; Luise Meurer
Journal:  Dig Dis Sci       Date:  2012-08-09       Impact factor: 3.199

4.  Effect of Low-Dose Aspirin on Chronic Acid Reflux Esophagitis in Rats.

Authors:  Takahiro Masuda; Fumiaki Yano; Nobuo Omura; Kazuto Tsuboi; Masato Hoshino; Se Ryung Yamamoto; Shunsuke Akimoto; Hideyuki Kashiwagi; Katsuhiko Yanaga
Journal:  Dig Dis Sci       Date:  2017-11-15       Impact factor: 3.199

5.  Dysphagia associated with gastroesophageal reflux disease is improved by proton pump inhibitor.

Authors:  Kayoko Oda; Ryuichi Iwakiri; Megumi Hara; Kazuyo Watanabe; Akiko Danjo; Ryo Shimoda; Atsushi Kikkawa; Akifumi Ootani; Hiroyuki Sakata; Seiji Tsunada; Kazuma Fujimoto
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

Review 6.  Functional oesophageal epithelial defense against acid.

Authors:  Yasuhiro Fujiwara; Kazuhide Higuchi; Kazunari Tominaga; Toshio Watanabe; Nobuhide Oshitani; Tetsuo Arakawa
Journal:  Inflammopharmacology       Date:  2005       Impact factor: 4.473

7.  Roles of cyclooxygenase 2 and microsomal prostaglandin E synthase 1 in rat acid reflux oesophagitis.

Authors:  T Hayakawa; Y Fujiwara; M Hamaguchi; T Sugawa; M Okuyama; E Sasaki; T Watanabe; K Tominaga; N Oshitani; K Higuchi; T Arakawa
Journal:  Gut       Date:  2005-10-06       Impact factor: 23.059

8.  Enhanced expression of epidermal growth factor receptor gene in gastric mucosal cells by the serum derived from rats treated with electroacupuncture at stomach meridian acupoints.

Authors:  Zong-Bao Yang; Jie Yan; Xiao-Ping Zou; Shou-Xiang Yi; Xiao-Rong Chang; Ya-Ping Lin; Xi-Ping Li
Journal:  World J Gastroenterol       Date:  2006-09-14       Impact factor: 5.742

9.  Berberine protects against esophageal mucosal damage in reflux esophagitis by suppressing proinflammatory cytokines.

Authors:  Byung Kil Choo; Seong-Soo Roh
Journal:  Exp Ther Med       Date:  2013-07-04       Impact factor: 2.447

10.  Chronic gastroesophageal reflux disease shares genetic background with esophageal adenocarcinoma and Barrett's esophagus.

Authors:  Puya Gharahkhani; Joyce Tung; David Hinds; Aniket Mishra; Thomas L Vaughan; David C Whiteman; Stuart MacGregor
Journal:  Hum Mol Genet       Date:  2015-12-23       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.